MAM
GLMD icon

McCarthy Asset Management’s Galmed Pharmaceuticals GLMD Stock Holding History

McCarthy Asset Management’s Portfolio GLMD Stock Details GLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4
Closed -$1K – 131
2022
Q1 		$1K Hold
4
– – ﹤0.01% 315
2021
Q4 		$1K Hold
4
– – ﹤0.01% 312
2021
Q3 		$2K Hold
4
– – ﹤0.01% 278
2021
Q2 		$2K Hold
4
– – ﹤0.01% 333
2021
Q1 		$2K Hold
4
– – ﹤0.01% 293
2020
Q4 		$2K Buy
+4
New +$2.5K ﹤0.01% 272

Other funds holding GLMD

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

McCarthy Asset Management's GLMD Position: Q2 2022 in Review

McCarthy Asset Management sold out of Galmed Pharmaceuticals (GLMD) in Q2 2022, closing a stake of 4 shares — an estimated $1K sold.

McCarthy Asset Management first reported a position in GLMD in Q4 2020 and held it in 6 quarters. The position peaked at $2K in Q3 2021. 22 funds tracked by Wall St. Rank hold GLMD as of Q2 2022.

  • McCarthy Asset Management reported no remaining Galmed Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • McCarthy Asset Management sold 4 Galmed Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • McCarthy Asset Management first reported a position in Galmed Pharmaceuticals in Q4 2020 and held it in 6 quarters.
  • McCarthy Asset Management's Galmed Pharmaceuticals position peaked at $2K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Galmed Pharmaceuticals as of Q2 2022.

Based on McCarthy Asset Management's 13F filing for Q2 2022, filed 20 Jul 2022.